Literature DB >> 14688237

Molecular, biochemical and immunological analyses of canine pancreatic DNase I.

Yasushi Kaneko1, Haruo Takeshita, Kouichi Mogi, Tamiko Nakajima, Toshihiro Yasuda, Masako Itoi, Hiroyuki Kuwano, Koichiro Kishi.   

Abstract

The DNase I from canine pancreas was purified 260-fold to electrophoretic homogeneity with a 35% yield using three-step column chromatography. The activity of the purified enzyme was completely inhibited by 20 mM EDTA, an antibody specific to the purified enzyme and G-actin. A 1,373-bp cDNA encoding canine DNase I was constructed from the total canine pancreatic RNA using a rapid amplification of cDNA ends method, followed by sequencing. The mature canine DNase I protein was found to consist of 262 amino acids. A survey of DNase I in 13 different canine tissues revealed the highest levels of both DNase I enzyme activity and gene expression in the pancreas; therefore, the canine DNase I is of the pancreatic type. Phylogenetic and sequence identity analyses, studies of immunological properties and the tissue-distribution patterns of DNase I indicated that the canine enzyme is more closely related to the human DNase I than to other mammalian DNases I. Therefore, canine DNase I is found to be one of the best substitutes in studies of human DNase I.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14688237     DOI: 10.1093/jb/mvg196

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  3 in total

1.  Increased DNase I activity in diabetes might be associated with injury of pancreas.

Authors:  Bin Zhu; Yuewen Gong; Pengmin Chen; Haojun Zhang; Tingting Zhao; Ping Li
Journal:  Mol Cell Biochem       Date:  2014-03-28       Impact factor: 3.396

2.  Application of molecular fingerprinting for qualitative assessment of small-intestinal bacterial diversity in dogs.

Authors:  Jan S Suchodolski; Craig G Ruaux; Jörg M Steiner; Kathrin Fetz; David A Williams
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

3.  DNase I aggravates islet β-cell apoptosis in type 2 diabetes.

Authors:  Bin Zhu; Lei Zhang; Yue-Ying Zhang; Lei Wang; Xin-Gang Li; Teng Liu; Yu-Ke Fu; Yan-Fei Zheng; Ping Li; Zhi-Gang Zhao
Journal:  Mol Med Rep       Date:  2016-04-11       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.